Superluminal Medicines

Recent Finacing

Seed

Recent Raise

$33M

Superluminal Medicines is a generative biology and chemistry company that uses machine learning and big data to advance small molecule drug discovery programs, with a focus on high-value G protein-coupled receptor (GPCR) targets.